| 書(shū)目名稱(chēng) | Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins |
| 編輯 | Ulf Grawunder,Stefan Barth |
| 視頻video | http://file.papertrans.cn/667/666181/666181.mp4 |
| 概述 | Offers cutting-edge information on the development of antibody drug conjugates and recombinant immunotoxins.Explores related basic biological and chemical technologies and promotes new developments to |
| 叢書(shū)名稱(chēng) | Milestones in Drug Therapy |
| 圖書(shū)封面 |  |
| 描述 | .This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.. .The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.. |
| 出版日期 | Book 2017 |
| 關(guān)鍵詞 | Antibody based cancer therapy; Antibody drug conjugates (ADC); Immunotoxin development; Pyrrolobenzodia |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-46877-8 |
| isbn_softcover | 978-3-319-83609-6 |
| isbn_ebook | 978-3-319-46877-8Series ISSN 2296-6056 Series E-ISSN 2296-6064 |
| issn_series | 2296-6056 |
| copyright | Springer International Publishing AG 2017 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-6 10:32
發(fā)表于 2025-3-21 19:11:04
